Tekla Capital Management LLC
- SEC CIK
- 0001300336
- Latest filing
- Aug 10, 2023
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Tekla Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2023 holdings
- Shares (Q2 2023)
- 173,248
- Value
- $15.8M
- % of portfolio
- 0.6%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 173,248 | $15.8M | 0.6% | +38,124+28.2% | Added | Holders |
| Q1 2023 | 135,124 | $8.91M | 0.3% | +68,698+103.4% | Added | Holders |
| Q4 2022 | 66,426 | $3.43M | 0.1% | −199,650−75.0% | Reduced | Holders |
| Q3 2022 | 266,076 | $18.2M | 0.7% | −46,116−14.8% | Reduced | Holders |
| Q2 2022 | 312,192 | $14.1M | 0.6% | +116,372+59.4% | Added | Holders |
| Q1 2022 | 195,820 | $9.95M | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 195,820 | $9.26M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 195,820 | $6.45M | 0.2% | +43,282+28.4% | Added | Holders |
| Q2 2021 | 152,538 | $9.64M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2021 | 152,538 | $6.54M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.